CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 166.48
+8.66 (5.49%)
Aug 19, 2026, 4:14 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 79.73 billion as of August 19, 2026. Its market cap has decreased by -39.31% in one year.
Market Cap
79.73B
Enterprise Value
95.48B
Revenue
22.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
166.48
ChartMarket Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 79.73B, an increase of 25,454.51%. That is a compound annual growth rate of 18.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 79.73B | -4.22% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.68B |
| Neuren Pharmaceuticals | 2.97B |
| Mesoblast | 2.87B |
| PYC Therapeutics | 2.10B |
| Clarity Pharmaceuticals | 981.20M |
| Clinuvel Pharmaceuticals | 481.59M |
| Racura Oncology | 390.14M |
| Tetratherix | 353.88M |